Calminax

Here we look at the claims for Calminax.

Version: 1.0 Last updated: April 2023 To be reviewed: November 2025

Treatment details

Illustration of a bottle with a star on the front of it.

Type

Branded dietary supplement

3

Safety

Evidence of harm

3

Efficacy

Evidence that it is not effective

Recommended?

No

The makers claim

None made[1].

What is the treatment?

Calminax is a capsule taken once daily[1].

The ingredients of Calminax are listed as Ginkgo biloba extract, vitamin B6, vitamin B12, zinc and magnesium[1].

Other sites listing Calminax list different ingredients for this supplement.

What are the downsides of this treatment?

Potential side effects, allergic reactions and drug interactions from Ginkgo biloba2. Magnesium can cause minor but unpleasant side effects[3].

Cost – it is listed for £44.95 for 30 days supply[1].

Has there been research into this treatment?

Although there have been no papers published on Calminax as a supplement, there are a number of papers on the effects of its component parts.

What does the research say?

The limited evidence does not demonstrate that Ginkgo biloba is effective for tinnitus when this is the primary complaint.[4] It does not reduce the intensity of tinnitus or improve quality of life.[5]

There is no evidence that the use of a zinc supplement[6] [7] or vitamin B6[8] improves symptoms in adults with tinnitus. Vitamin B6 can be harmful in large doses[8].

There is limited evidence that vitamin B12[9] and magnesium[10] may help tinnitus in people who are deficient in these elements.

Although independent evidence is limited, what there is does not show that the components of this supplement are effective for tinnitus. The potential side effects may cause serious harm. We would suggest you talk to your GP before taking any new medication or supplement.

“Dietary supplements should not be recommended to treat tinnitus”[11]

Tinnitus UK

Comments

Practice guidelines do not recommend the use of Ginkgo biloba as a treatment for tinnitus[12] [13].

All online references accessed 11 November 2022 unless noted.

1. Seen on TV deal. Arches Calminax 30 capsules. https://seenontvdeal.co.uk/products/calminax?variant=14063342747709

2. Drugsite Trust. Ginkgo biloba. Available from https://www.drugs.com/cdi/ginkgo-biloba.html

3. National Institutes of Health Office of Dietary Supplements. Magnesium. www.ods.od.nih.gov/factsheets/magnesium-Consumer/

4. Hilton MP, Zimmermann EF, Hunt WT. Ginkgo biloba for tinnitus. Cochrane Database of Systematic Reviews (2013), Issue 3. Art. No.: CD003852. doi:
10.1002/14651858.CD003852.pub3.

5. Kramer F, Ortigoza Á. Ginkgo biloba for the treatment of tinnitus. Medwave. (2018) Oct 17;18(6):e7295.
English, Spanish. doi: 10.5867/
medwave.2018.06.7294. Erratum in:
Medwave. (2018) Nov 13;18(7):e7337.

6. Person OC, Puga MES, da Silva EMK, Torloni MR. Zinc supplements for tinnitus.
Cochrane Database of Systematic Reviews
(2016), Issue 11. Art. No.: CD009832.
DOI: 10.1002/14651858.CD009832.pub2.

7. National Institutes of Health Office of Dietary Supplements. Zinc Fact Sheet for Consumers. www.ods.od.nih.gov/factsheets/zinc-Consumer/

8. National Institutes of Health Office of Dietary Supplements. Vitamin B6. www.ods.od.nih.gov/factsheets/VitaminB6-Consumer/

9. Singh C, Kawatra R, Gupta J, Awasthi V, Dungana H. Therapeutic role of Vitamin B12 in patients of chronic tinnitus: A pilot study. Noise and Health. (2016) Mar-Apr;18(81):93-7. doi: 10.4103/1463-
1741.178485.

10. Cevette MJ, Barrs DM, Patel A, et al. Phase 2 study examining magnesium-dependent tinnitus. International Tinnitus Journal. (2011);16(2):168-73

11. Coelho C, Tyler R et al. Survey on the Effectiveness of Dietary Supplements to Treat Tinnitus. American Journal of Audiology. (2016) 25(3): 184-205

12. British Society of Audiology. Practice Guidance – Tinnitus in Adults. (2021) Available from: www.thebsa.org.uk/resources/practice-guidance-tinnitus-in-adults/

13. Tunkel DE, Bauer CA, Sun GH, et al. Clinical Practice Guideline: Tinnitus. Otolaryngology–Head and Neck Surgery. (2014);151(2_suppl): S1-S40.
doi:10.1177/0194599814545325